LENZ Therapeutics, Inc. (LENZ)
4.60
-0.08
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
4.60
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Total Assets (Quarterly) : 236.60M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 236.60M |
| March 31, 2026 | 272.54M |
| December 31, 2025 | 305.88M |
| September 30, 2025 | 210.70M |
| June 30, 2025 | 217.33M |
| March 31, 2025 | 201.25M |
| December 31, 2024 | 215.30M |
| September 30, 2024 | 224.01M |
| June 30, 2024 | 202.64M |
| March 31, 2024 | 217.32M |
| December 31, 2023 | 70.38M |
| September 30, 2023 | 266.23M |
| Date | Value |
|---|---|
| June 30, 2023 | 287.04M |
| March 31, 2023 | 310.00M |
| December 31, 2022 | 321.90M |
| September 30, 2022 | 334.84M |
| June 30, 2022 | 353.79M |
| March 31, 2022 | 378.61M |
| December 31, 2021 | 401.99M |
| September 30, 2021 | 416.15M |
| June 30, 2021 | 387.11M |
| March 31, 2021 | 182.91M |
| December 31, 2020 | 22.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 671.32M |
| Enveric Biosciences, Inc. | 8.944M |
| Liquidia Corp. | 521.92M |
| Aquestive Therapeutics, Inc. | 132.10M |
| Impact BioMedical, Inc. | 16.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.33M |
| Shareholders Equity (Quarterly) | 219.26M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 13.55 |
| Net Debt Paydown Yield | 0.07% |